
|Articles|June 1, 2003
Quick Psoriasis Solution
San Francisco - Etanercept (Enbrel) produces rapid, significant, and sustained improvement in symptoms in patients with moderate to severe psoriasis, according to the results of a large, multicenter Phase III study presented by Alice Gottlieb, MD, Ph.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
2
The Aesthetic Edge: January 2026
3
LEVEL UP Study Shows Benefits of Switching From Dupilumab to Upadacitinib in AD
4
Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa
5



















